buyWeak cluster of 2
Ivana Magovcevic-Liebisch bought $8,350 of VIGL
President and CEO at Vigil Neuroscience, Inc.. 5,000 shares at an average of $1.67, traded Dec 18, 2024, filed Dec 18, 2024.
Conviction score
38Value
$8,350
5,000 shares
Holdings after
217,687
+2% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +25RoleCEO
- 0Trade size$8k at market
- 0Relative to holdingsHoldings up 2.4%
- 0Price contextNo price history yet
- +8Cluster2 insiders buying within 14 days
- +5Repeat buying2 buys in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0000950170-24-138012, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 18, 2024 | POpen-market purchase Common Stock | +5,000 | $1.67 | $8,350 | 217,687 | Dec 18, 2024 |
Related signals
Other insiders at Vigil Neuroscience, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 31Weak | Vigil Neuroscience, Inc. | Haeberlein Samantha L. Budd director | $21k 12,000 shares | - | |
| 38Weak | Vigil Neuroscience, Inc. | Ivana Magovcevic-Liebisch President and CEO | $8,400 5,000 shares | +2% | |
| 33Weak | Vigil Neuroscience, Inc. | Ivana Magovcevic-Liebisch President and CEO | $12k 5,000 shares | +2% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.